Pancreatic Cancer Research

RetractionCancer Cell Int2019

Retraction Note to: Excessive mitochondrial fragmentation triggered by erlotinib promotes pancreatic cancer PANC‑1 cell apoptosis via activating the mROS‑HtrA2/Omi pathways.

Journal
Cancer Cell Int
Published
12 November 2019
Citations
1
Type
Retraction
License
cc by
Full text
Open access, reuse-licensed (cc by)
Retracted
Yes

These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Its licensed text is not loaded here yet, so most questions will be declined.

Try